Software Healthcare Sector

Retrieve Medical Holdings

Market Cap: US$30.2m

Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.

Angion Biomedica

Market Cap: US$30.1m

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States.

Sernova Biotherapeutics

Market Cap: CA$41.5m

Operates as a clinical-stage biotechnology company in Canada.

BeyondSpring

Market Cap: US$29.2m

A clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Medicenna Therapeutics

Market Cap: CA$40.2m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

TELA Bio

Market Cap: US$29.0m

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

ImmuPharma

Market Cap: UK£21.2m

Engages in the research, development, and commercialization of peptide-based therapeutics for autoimmune diseases, infectious diseases, and metabolic disorders in the United Kingdom and internationally.

NanoViricides

Market Cap: US$28.9m

A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.

Perimeter Medical Imaging AI

Market Cap: CA$39.9m

A medical technology company, provides advanced imaging solutions to address unmet medical needs.

Nova Eye Medical

Market Cap: AU$39.9m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

CRUSHMETRIC Group

Market Cap: UK£20.9m

Engages in design and production that integrates shape changing technology into catalogue of products in Hong Kong, Mainland China, and Singapore.

Healixa

Market Cap: US$28.5m

Operates as a technology company with assets in both healthtech and fintech.

ZYUS Life Sciences

Market Cap: CA$39.9m

Manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational.

Evaxion

Market Cap: US$28.4m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Raphael Pharmaceutical

Market Cap: US$28.2m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.

Microba Life Sciences

Market Cap: AU$39.4m

Provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.

Optimi Health

Market Cap: CA$38.5m

Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Quantum BioPharma

Market Cap: CA$38.0m

Operates as a biopharmaceutical company.

Defence Therapeutics

Market Cap: CA$37.9m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

Rubicon Organics

Market Cap: CA$37.8m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Earth Science Tech

Market Cap: US$27.3m

Together with its subsidies, focuses on health and wellness industry.

HeartBeam

Market Cap: US$27.2m

Operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.

Greenland Mines

Market Cap: US$27.2m

Engages in the cell and gene therapy, and natural resources businesses.

Genenta Science

Market Cap: US$27.1m

A clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Vivos

Market Cap: US$27.1m

A radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States.

Voyageur Pharmaceuticals

Market Cap: CA$37.3m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Lantern Pharma

Market Cap: US$27.0m

Focuses on the discovery and development of oncology drug in India.

NextCure

Market Cap: US$27.0m

A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.

1CM

Market Cap: CA$37.1m

A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.

Longeveron

Market Cap: US$26.7m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Harvard Apparatus Regenerative Technology

Market Cap: US$26.7m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.

SafeSpace Global

Market Cap: US$26.6m

Through its subsidiaries, operates as a multimodal AI technology solutions company in the United States, Europe, Singapore, and India.

Rhythm Biosciences

Market Cap: AU$37.2m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States.

PetVivo Holdings

Market Cap: US$26.5m

A biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States.

More Life

Market Cap: CA$36.6m

A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.